{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:12:58Z","timestamp":1759057978413},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.2169\/internalmedicine.5074-20","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:10:21Z","timestamp":1594678221000},"page":"2777-2781","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Slowly Progressive Myelitis and Longitudinally Extensive Spinal Cord Lesions"],"prefix":"10.2169","volume":"59","author":[{"given":"Takuya","family":"Kudo","sequence":"first","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Higashida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73: 1297-1307, 2016."},{"key":"2","unstructured":"2. Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81: 298-309, 2017."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol 332: 91-98, 2019.","DOI":"10.1016\/j.jneuroim.2019.04.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 32: 452-458, 2019.","DOI":"10.1097\/WCO.0000000000000676"},{"key":"5","unstructured":"5. Iorio R, Damato V, Evoli A, et al. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry 89: 138-146, 2018."},{"key":"6","unstructured":"6. Sechi E, Morris PP, McKeon A, et al. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry 90: 488-490, 2019."},{"key":"7","unstructured":"7. Dubey D, Hinson SR, Jolliffe EA, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year. J Neuroimmunol 321: 157-163, 2018."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tomczak A, Su E, Tugizova M, et al. A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism. Mult Scler Relat Disord 39: 101900, 2019.","DOI":"10.1016\/j.msard.2019.101900"},{"key":"9","unstructured":"9. Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol 25: 477-483, 2018."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Shu Y, Long Y, Chang Y, et al. Brain immunohistopathology in a patient with autoimmune glial fibrillary acidic protein astrocytopathy. Neuroimmunomodulation 25: 1-6, 2018.","DOI":"10.1159\/000488879"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tokimura R, Matsuda N, Kobayashi S, Kimura A, Kanai K. Abnormal evoked potentials in autoimmune glial fibrillary acidic protein astrocytopathy. eNeurologicalSci 18: 100229, 2020.","DOI":"10.1016\/j.ensci.2020.100229"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bolat S, Berding G, Dengler R, Stangel M, Trebst C. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci 287: 257-259, 2009.","DOI":"10.1016\/j.jns.2009.08.060"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Flanagan EP, Hunt CH, Lowe V, et al. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc 88: 1204-1212, 2013.","DOI":"10.1016\/j.mayocp.2013.07.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ip B, Lam C, Ip V, et al. Autoimmune glial fibillary acidic protein astrocytopathy associated meningoencephalomyelitis and bilateral sensorineuronal deafness. Mult Scler Relat Disord 40: 101922, 2019.","DOI":"10.1016\/j.msard.2019.101922"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Allen A, Gulhar S, Haidari R, et al. Autoimmune glial fibrillary acidic protein astrocytopathy resulting in treatment-refractory flaccid paralysis. Mult Scler Relat Disord 39: 101924, 2020.","DOI":"10.1016\/j.msard.2019.101924"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5074-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:48:41Z","timestamp":1604720921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5074-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":15,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5074-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}